These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 22832924)

  • 1. Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice.
    Rieg T; Gerasimova M; Murray F; Masuda T; Tang T; Rose M; Drucker DJ; Vallon V
    Am J Physiol Renal Physiol; 2012 Oct; 303(7):F963-71. PubMed ID: 22832924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection.
    Katagiri D; Hamasaki Y; Doi K; Okamoto K; Negishi K; Nangaku M; Noiri E
    J Am Soc Nephrol; 2013 Dec; 24(12):2034-43. PubMed ID: 24092928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diuretic and Natriuretic Effects of Dipeptidyl Peptidase-4 Inhibitor Teneligliptin: The Contribution of Glucagon-like Peptide-1.
    Moroi M; Kubota T
    J Cardiovasc Pharmacol; 2015 Aug; 66(2):159-64. PubMed ID: 25853991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon-like peptide 1 and dipeptidyl peptidase 4.
    Vallon V; Docherty NG
    Exp Physiol; 2014 Sep; 99(9):1140-5. PubMed ID: 25085841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1.
    Crajoinas RO; Oricchio FT; Pessoa TD; Pacheco BP; Lessa LM; Malnic G; Girardi AC
    Am J Physiol Renal Physiol; 2011 Aug; 301(2):F355-63. PubMed ID: 21593184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacologic basis for clinical differences among GLP-1 receptor agonists and DPP-4 inhibitors.
    Morales J
    Postgrad Med; 2011 Nov; 123(6):189-201. PubMed ID: 22104467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory role of DPP-4 inhibitors in a nondiabetic model of glomerular injury.
    Higashijima Y; Tanaka T; Yamaguchi J; Tanaka S; Nangaku M
    Am J Physiol Renal Physiol; 2015 Apr; 308(8):F878-87. PubMed ID: 25656369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The physiological role of glucagon-like peptide-1 in the regulation of renal function.
    Farah LX; Valentini V; Pessoa TD; Malnic G; McDonough AA; Girardi AC
    Am J Physiol Renal Physiol; 2016 Jan; 310(2):F123-7. PubMed ID: 26447224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
    Mann RJ; Nasr NE; Sinfield JK; Paci E; Donnelly D
    Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.
    Maida A; Hansotia T; Longuet C; Seino Y; Drucker DJ
    Gastroenterology; 2009 Dec; 137(6):2146-57. PubMed ID: 19766644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
    Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
    Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways.
    Shah Z; Pineda C; Kampfrath T; Maiseyeu A; Ying Z; Racoma I; Deiuliis J; Xu X; Sun Q; Moffatt-Bruce S; Villamena F; Rajagopalan S
    Vascul Pharmacol; 2011; 55(1-3):2-9. PubMed ID: 21397040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Renal Sympathetic Nerves in GLP-1 (Glucagon-Like Peptide-1) Receptor Agonist Exendin-4-Mediated Diuresis and Natriuresis in Diet-Induced Obese Rats.
    Liu X; Patel KP; Zheng H
    J Am Heart Assoc; 2021 Nov; 10(21):e022542. PubMed ID: 34713714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats.
    Liu WJ; Xie SH; Liu YN; Kim W; Jin HY; Park SK; Shao YM; Park TS
    J Pharmacol Exp Ther; 2012 Feb; 340(2):248-55. PubMed ID: 22025647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells.
    Schlatter P; Beglinger C; Drewe J; Gutmann H
    Regul Pept; 2007 Jun; 141(1-3):120-8. PubMed ID: 17276524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor.
    Tatarkiewicz K; Sablan EJ; Polizzi CJ; Villescaz C; Parkes DG
    Am J Physiol Regul Integr Comp Physiol; 2014 Apr; 306(7):R490-8. PubMed ID: 24477544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
    Holst JJ
    Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.
    Barrera JG; D'Alessio DA; Drucker DJ; Woods SC; Seeley RJ
    Diabetes; 2009 Dec; 58(12):2820-7. PubMed ID: 19741167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.
    Nauck MA; Meier JJ; Cavender MA; Abd El Aziz M; Drucker DJ
    Circulation; 2017 Aug; 136(9):849-870. PubMed ID: 28847797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 receptor stimulation increases GFR and suppresses proximal reabsorption in the rat.
    Thomson SC; Kashkouli A; Singh P
    Am J Physiol Renal Physiol; 2013 Jan; 304(2):F137-44. PubMed ID: 23019232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.